gene

SLC17A5

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SLC17A5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

70Connections
0Hypotheses
0Analyses
45Outgoing
25Incoming

Summary

SLC17A5 is a gene implicated in neurodegeneration research. Key relationships include: associated with, implicated in, contributes to. Associated with Aging, Als, Ms. Connected to 10 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolSLC17A5
Full NameSolute Carrier Family 17 Member 5 (Sialin)
Chromosome6q13
Functionis an important component in the neurobiology of neurodegenerative diseases.
Amino Acids495 aa
Exons14
PathwaysAlpha-Synuclein, Cholesterol
UniProt ID[Q9NRX3](https://www.uniprot.org/uniprot/Q9NRX3)
Ensembl IDENSG00000183040
GeneCardsSLC17A5
Human Protein AtlasSLC17A5
Exon count14 exons spanning approximately 25 kb
Promoter regionContains regulatory elements for tissue-specific expression
Coding sequenceEncodes a polytopic membrane protein with 10-12 transmembrane domains
Lysosomal exportExports sialic acid from lysosomes using the proton gradient as energy source[@sialin2019]
Associated DiseasesALS, Aging, Ms, Parkinson
InteractionsGNPTAB, SMPD1, NPC1, GBA, CTSD, LIPA
KG Connections70 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Wiki Pages (9)

Knowledge base pages for this entity

Canonical Page

SLC17A5 Gene

gene · 764 words

VGLUT2 Gene

gene · 2948 words

Lysosomal Autophagy Neuron

cell_type · 1548 words

GNPTAB — N-Acetylglucosamine-1-Phosphate Transferase Alpha/Beta

gene · 1500 words

ASAH1 — N-Acylsphingosine Amidohydrolase 1

gene · 1077 words

Nucleus Tractus Solitarius Neurons

cell · 1051 words

Pathway Diagram

graph TD
    SLC17A5["<b>SLC17A5</b>"]
    Parkinson_s_disease{"Parkinson's disease"}
    SLC17A5 -->|"contributes to"| Parkinson_s_disease
    Parkinson{"Parkinson"}
    SLC17A5 -->|"associated with"| Parkinson
    Als{"Als"}
    SLC17A5 -->|"associated with"| Als
    Aging{"Aging"}
    SLC17A5 -->|"associated with"| Aging
    Ms{"Ms"}
    SLC17A5 -->|"associated with"| Ms
    GBA["GBA"]
    SLC17A5 -->|"associated with"| GBA
    neurodegeneration["neurodegeneration"]
    SLC17A5 -->|"implicated in"| neurodegeneration
    GENES["GENES"]
    GENES -->|"associated with"| SLC17A5
    SMPD1["SMPD1"]
    SMPD1 -->|"associated with"| SLC17A5
    CTSD["CTSD"]
    CTSD -->|"associated with"| SLC17A5
    style SLC17A5 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (45)

TargetRelationTypeStr
Alpha-Synuclein Neurotoxicitymodulatesphenotype0.85
Parkinson's diseasecontributes_todisease0.80
Retinal Degenerationactivatesdisease0.65
Parkinsonassociated_withdisease0.65
Alsassociated_withdisease0.65

Incoming (25)

SourceRelationTypeStr
SMPD1associated_withgene0.60
CTSDassociated_withgene0.60
SCARB2activatesgene0.60
LIPAactivatesgene0.60
ASAH1associated_withgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found